Trend
DailyUptrend (confirmed)
4 hourExpanding
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $4.71
Key levels
Resistance$4.91
Resistance$4.37
Support$2.89
Support$1.90
Latest news & SEC filings
No headlines in the last 90 days.
CNS Pharmaceuticals is a biotechnology company developing therapies for neurology and oncology. It is shifting from its earlier focus on brain cancer compounds toward acquiring or licensing preclinical and clinical-stage assets in these areas. The company seeks treatments for serious diseases with limited options, aiming to build a pipeline of differentiated therapies.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CNSP.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/B, PEG
Fair Value
$2.96
12
Moat Score
NONE
1/9
Piotroski Score
-21.5
Altman Z-Score
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Charles Faith L. | director | Buy | 7,100 | $34K | May 18, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
92.34%
FCF Growth YoY
19.2%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for CNSP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:23:51 | $3.92 | 1,000 | $$4K | SELL |
| 17:20:36 | $4.00 | 1,500 | $$6K | BUY |
| 17:03:11 | $4.65 | 1,487 | $$7K | BUY |
| 14:04:47 | $5.00 | 1,071 | $$5K | SELL |
| 19:42:20 | $5.06 | 1,817 | $$9K | SELL |
5 dark pool trades shown · $$31K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for CNS Pharmaceuticals, Inc. (CNSP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CNS Pharmaceuticals, Inc. (CNSP) is at $3.71, down 3.64% (-$0.14) at the Nov 11, 2026 close.
CNSP last reported on Aug 12, 2026: EPS -$0.38 vs -$0.24 expected — a miss of 58.3%.
CNSP does not currently pay a dividend.
Support: $2.89, $1.90. Resistance: $4.37, $4.91, $5.50.
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.